Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EN3835 for Uterine Fibroids
NCT02889848Phase 1Completed
- Sponsor
- Advance Biofactures
- Start
- Oct 2016
- Primary completion
- Oct 2018
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
Phase 1, open-label trial of collagenase clostridium histolyticum in uterine leiomyoma (5 arms), sponsored by Advance Biofactures. Primary endpoint: Number of participants with treatment-related adverse events. Started Oct 2016; status: completed.
02
Drugs
collagenase clostridium histolyticum
03
Conditions
uterine leiomyoma
Beyond the preview
Go deeper on NCT02889848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02889848.